Review
. 2017 Feb;7().
doi: 10.1016/j.bbacli.2017.01.001.

Understanding breast cancer - The long and winding road

Kiven Erique Lukong 1 
Affiliations
  • PMID: 28194329
  •     83 References
  •     35 citations

Abstract

Background: Despite a remarkable increase in the depth of our understanding and management of breast cancer in the past 50 years, the disease is still a major public health problem worldwide and poses significant challenges. The palpability of breast tumors has facilitated diagnosis and documentation since ancient times. The earliest descriptions of breast cancer date back to around 3500 BCE. For centuries to follow, theories by Hippocrates (460 BCE) and Galen (200 CE), attributing the cause of breast cancer to an "excess of black bile" and treatment options including the use of opium and castor oil, prevailed. Surgical resection was introduced in the 18th century. The advent of modern medicine led to the development of novel treatment options that include hormonal, targeted and chemo-therapies. There are still several therapeutic challenges including the treatment of triple negative breast cancer (TNBC), and overcoming drug resistance.

Scope Of Review: The increased incidence and awareness of breast cancer has led to significant changes in diagnosis and treatment in recent decades. But, mankind has come a long way. Herein, I have traced how our understanding of breast cancer has evolved from the early description of the disease around 460 BCE as "black bile-containing crab-like tumors" to the conventional as a heterogeneous disease with high degree of diversity between and within tumors, as well as among breast cancer patients. How is breast cancer treated today and how do risk factors, breast cancer subtype and drug resistance contribute to the therapeutic challenges at the turn of the 21st century?

Major Conclusions: Breast cancer remains a serious public health issue worldwide. However, appreciable growth in our understanding of breast cancer in the past century has led to remarkable progress in the early detection, treatment and prevention of the disease. The clinical focus is shifting more towards tailored therapy as more targets are characterized and novel highly innovative approaches are developed.

General Significance: Tracing the history of breast cancer, highlights how increased awareness of the disease, and progress in research and development have enhance our understanding of the disease.

Keywords: Angelina Jolie; Aromatase inhibitors; BRCA1 and BRCA2; Breast cancer; ER; HER2; Herceptin; Hippocrates; Mammography; Radical mastectomy; Tamoxifen; Triple negative breast cancer (TNBC).

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, +6 authors, Freddie Bray.
Int J Cancer, 2014 Sep 16; 136(5). PMID: 25220842
Highly Cited.
Similarities and distinctions in the mode of action of different classes of antioestrogens.
A E Wakeling.
Endocr Relat Cancer, 2000 May 16; 7(1). PMID: 10808193
Review.
On Oöphorectomy in the Treatment of Cancer.
S Boyd.
Br Med J, 1897 Oct 02; 2(1918). PMID: 20757318    Free PMC article.
Ancient Greek and Greco-Roman methods in modern surgical treatment of cancer.
Niki Papavramidou, Theodossis Papavramidis, Thespis Demetriou.
Ann Surg Oncol, 2010 Jan 06; 17(3). PMID: 20049643    Free PMC article.
Bloody nipple discharge is a predictor of breast cancer risk: a meta-analysis.
Ling Chen, Wen-Bin Zhou, +4 authors, Shui Wang.
Breast Cancer Res Treat, 2011 Sep 29; 132(1). PMID: 21947751
Review.
Breastfeeding and the prevention of breast cancer: a retrospective review of clinical histories.
Emilio González-Jiménez, Pedro A García, +2 authors, Judit Álvarez.
J Clin Nurs, 2013 Aug 14; 23(17-18). PMID: 23937211
History of surgery for breast cancer: radical to the sublime.
Alvin M Cotlar, Joseph J Dubose, D Michael Rose.
Curr Surg, 2004 Feb 20; 60(3). PMID: 14972270
Franciscus Sylvius (1614-1672): a historical review.
R Shane Tubbs, Sanjay Linganna, Marios Loukas.
Childs Nerv Syst, 2006 Nov 11; 23(1). PMID: 17096165
Risk factors for breast cancer: a reanalysis of two case-control studies from 1926 and 1931.
David J Press, Paul Pharoah.
Epidemiology, 2010 May 26; 21(4). PMID: 20498604
Current strategies for the prevention of breast cancer.
Pooja Advani, Alvaro Moreno-Aspitia.
Breast Cancer (Dove Med Press), 2014 May 17; 6. PMID: 24833917    Free PMC article.
Review.
Gene expression profiling in breast cancer.
Shannon R Morris, Lisa A Carey.
Curr Opin Oncol, 2007 Oct 02; 19(6). PMID: 17906450
Review.
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, +20 authors, Timothy R Rebbeck.
JAMA, 2010 Sep 03; 304(9). PMID: 20810374    Free PMC article.
Highly Cited.
New selective estrogen and androgen receptor modulators.
Bart L Clarke, Sundeep Khosla.
Curr Opin Rheumatol, 2009 May 05; 21(4). PMID: 19412100    Free PMC article.
Review.
Commentary on the significance for modern neurology of the 17th century B.C. Surgical Papyrus.
C M Helgason.
Can J Neurol Sci, 1987 Nov 01; 14(4). PMID: 3319119
Cancer stem cells and their implication in breast cancer.
E Carrasco, Pablo J Alvarez, +4 authors, Fernando Rodríguez-Serrano.
Eur J Clin Invest, 2014 Apr 29; 44(7). PMID: 24766664
Review.
Wilhelm Conrad Röentgen (1845-1923), the discovery of x rays and perinatal diagnosis.
P M Dunn.
Arch Dis Child Fetal Neonatal Ed, 2001 Feb 24; 84(2). PMID: 11207235    Free PMC article.
Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA.
Erin L Hayes, Joan S Lewis-Wambi.
Breast Cancer Res, 2015 Apr 08; 17. PMID: 25849966    Free PMC article.
Highly Cited. Review.
Ado-trastuzumab Emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer.
John M Lambert, Ravi V J Chari.
J Med Chem, 2014 Jun 27; 57(16). PMID: 24967516
Highly Cited.
Molecular portraits of human breast tumours.
C M Perou, T Sørlie, +15 authors, D Botstein.
Nature, 2000 Aug 30; 406(6797). PMID: 10963602
Highly Cited.
Tamoxifen: a most unlikely pioneering medicine.
V Craig Jordan.
Nat Rev Drug Discov, 2003 Mar 04; 2(3). PMID: 12612646
Highly Cited. Review.
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.
D J Slamon, G M Clark, +3 authors, W L McGuire.
Science, 1987 Jan 09; 235(4785). PMID: 3798106
Highly Cited.
Breast cancer genes: looking for BRACA's lost brother.
Borys A Cornejo-Moreno, Diego Uribe-Escamilla, Fabio Salamanca-Gómez.
Isr Med Assoc J, 2015 Jan 30; 16(12). PMID: 25630211
Review.
Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature.
María Teresa Martínez, José Alejandro Pérez-Fidalgo, +6 authors, Ana Lluch.
Crit Rev Oncol Hematol, 2015 Sep 01; 97. PMID: 26318092
Review.
Emerging targeted therapies in triple-negative breast cancer.
J Crown, J O'Shaughnessy, G Gullo.
Ann Oncol, 2012 Oct 04; 23 Suppl 6. PMID: 23012305
Highly Cited. Review.
No shrinking violet: Rose Kushner and the rise of American breast cancer activism.
B H Lerner.
West J Med, 2001 May 09; 174(5). PMID: 11342526    Free PMC article.
One hundred years of hormones.
Jamshed R Tata.
EMBO Rep, 2005 Jun 09; 6(6). PMID: 15940278    Free PMC article.
The Epidemiology of Male Breast Cancer.
Raina M Ferzoco, Kathryn J Ruddy.
Curr Oncol Rep, 2015 Dec 24; 18(1). PMID: 26694922
Review.
Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches.
Qiong Wu, Zhiping Yang, +2 authors, Daiming Fan.
Cancer Lett, 2014 Mar 25; 347(2). PMID: 24657660
Highly Cited. Review.
Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss.
Gayatri Arun, Sarah Diermeier, +10 authors, David L Spector.
Genes Dev, 2015 Dec 25; 30(1). PMID: 26701265    Free PMC article.
Highly Cited.
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.
T Yamamoto, S Ikawa, +5 authors, K Toyoshima.
Nature, 1986 Jan 16; 319(6050). PMID: 3003577
Highly Cited.
Molecular alterations in triple-negative breast cancer-the road to new treatment strategies.
Carsten Denkert, Cornelia Liedtke, Andrew Tutt, Gunter von Minckwitz.
Lancet, 2016 Dec 13; 389(10087). PMID: 27939063
Highly Cited. Review.
Iniparib, a PARP1 inhibitor for the potential treatment of cancer, including triple-negative breast cancer.
Hongyang Liang, Antoinette R Tan.
IDrugs, 2010 Aug 28; 13(9). PMID: 20799148
Review.
Deconstructing the molecular portraits of breast cancer.
Aleix Prat, Charles M Perou.
Mol Oncol, 2010 Dec 15; 5(1). PMID: 21147047    Free PMC article.
Highly Cited. Review.
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.
B Fisher, C Redmond, +7 authors, R Foster.
N Engl J Med, 1985 Mar 14; 312(11). PMID: 3883168
Highly Cited.
Risk factors. Oncotype DX assay predicts local recurrence in breast cancer.
Rebecca Kirk.
Nat Rev Clin Oncol, 2010 Jun 10; 7(6). PMID: 20527688
The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.
D Gareth Evans, Julian Barwell, +13 authors, Alex Murray.
Breast Cancer Res, 2014 Dec 17; 16(5). PMID: 25510853    Free PMC article.
Highly Cited.
Targeting a Long Noncoding RNA in Breast Cancer.
Joshua T Mendell.
N Engl J Med, 2016 Jun 09; 374(23). PMID: 27276568
Highly Cited.
Broad targeting of angiogenesis for cancer prevention and therapy.
Zongwei Wang, Charlotta Dabrosin, +29 authors, Lasse D Jensen.
Semin Cancer Biol, 2015 Jan 21; 35 Suppl. PMID: 25600295    Free PMC article.
Highly Cited. Review.
International Variation in Female Breast Cancer Incidence and Mortality Rates.
Carol E DeSantis, Freddie Bray, +3 authors, Ahmedin Jemal.
Cancer Epidemiol Biomarkers Prev, 2015 Sep 12; 24(10). PMID: 26359465
Highly Cited.
The fate of chemoresistance in triple negative breast cancer (TNBC).
Elma A O'Reilly, Luke Gubbins, +8 authors, Amanda McCann.
BBA Clin, 2015 Dec 18; 3. PMID: 26676166    Free PMC article.
Highly Cited. Review.
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, +7 authors, W Ding.
Science, 1994 Oct 07; 266(5182). PMID: 7545954
Highly Cited.
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.
Sandra M Swain, Sung-Bae Kim, +11 authors, José Baselga.
Lancet Oncol, 2013 Apr 23; 14(6). PMID: 23602601    Free PMC article.
Highly Cited.
Estrogen action: a historic perspective on the implications of considering alternative approaches.
Elwood V Jensen, Herbert I Jacobson, Alicia A Walf, Cheryl A Frye.
Physiol Behav, 2009 Sep 10; 99(2). PMID: 19737574    Free PMC article.
Review.
Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.
W J Muller, E Sinn, +2 authors, P Leder.
Cell, 1988 Jul 01; 54(1). PMID: 2898299
Highly Cited.
Breast cancer classification and prognosis based on gene expression profiles from a population-based study.
Christos Sotiriou, Soek-Ying Neo, +7 authors, Edison T Liu.
Proc Natl Acad Sci U S A, 2003 Aug 15; 100(18). PMID: 12917485    Free PMC article.
Highly Cited.
Exosomes and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment.
C-Y Wu, S-L Du, +2 authors, Y-J Liu.
Cancer Gene Ther, 2016 Dec 17; 24(1). PMID: 27982016
Review.
Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer.
Sayem Miah, Charles A S Banks, +3 authors, Michael P Washburn.
Mol Biosyst, 2016 Nov 29; 13(1). PMID: 27891540    Free PMC article.
Review.
Targeting HER2 for the treatment of breast cancer.
Mothaffar F Rimawi, Rachel Schiff, C Kent Osborne.
Annu Rev Med, 2015 Jan 15; 66. PMID: 25587647
Highly Cited. Review.
The evolution of mammography.
L W Bassett, R H Gold.
AJR Am J Roentgenol, 1988 Mar 01; 150(3). PMID: 3277343
Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, +7 authors, G Micklem.
Nature, 1995 Dec 21; 378(6559). PMID: 8524414
Highly Cited.
Hormone receptors: studies on the interaction of estrogen with the uterus.
J Gorski, D Toft, +2 authors, A Notides.
Recent Prog Horm Res, 1968 Jan 01; 24. PMID: 4885833
Highly Cited. Review.
Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.
B Fisher, M Bauer, +7 authors, E Montague.
N Engl J Med, 1985 Mar 14; 312(11). PMID: 3883167
Highly Cited.
Molecular testing in breast cancer.
Costanza Paoletti, Daniel F Hayes.
Annu Rev Med, 2014 Jan 16; 65. PMID: 24422569
Review.
Cancer statistics, 2013.
Rebecca Siegel, Deepa Naishadham, Ahmedin Jemal.
CA Cancer J Clin, 2013 Jan 22; 63(1). PMID: 23335087
Highly Cited.
Oncotype DX Test Offers Guidance For Women Debating Chemotherapy.
Bob Carlson.
Biotechnol Healthc, 2006 Aug 01; 3(4). PMID: 23424367    Free PMC article.
A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition.
Hans-Peter Sinn, Hans Kreipe.
Breast Care (Basel), 2014 Jan 15; 8(2). PMID: 24415964    Free PMC article.
Review.
Triple-negative/basal-like breast cancer: review.
Emad A Rakha, Ian O Ellis.
Pathology, 2008 Dec 18; 41(1). PMID: 19089739
Highly Cited. Review.
[History of mammography].
J D Picard.
Bull Acad Natl Med, 1999 Apr 03; 182(8). PMID: 10188307
Franciscus de le Boë or Sylvius 1614-72.
L F Haas.
J Neurol Neurosurg Psychiatry, 1992 Aug 01; 55(8). PMID: 1527548    Free PMC article.
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Christina Curtis, Sohrab P Shah, +29 authors, Samuel Aparicio.
Nature, 2012 Apr 24; 486(7403). PMID: 22522925    Free PMC article.
Highly Cited.
The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.
Sunil R Lakhani, Marc J Van De Vijver, +4 authors, Douglas F Easton.
J Clin Oncol, 2002 May 01; 20(9). PMID: 11981002
Highly Cited.
Percutaneous Image-Guided Cryoablation of Breast Cancer: A Systematic Review.
Ezio Lanza, Jean Palussiere, +6 authors, Roberto Luigi Cazzato.
J Vasc Interv Radiol, 2015 Sep 08; 26(11). PMID: 26342882
Systematic Review.
Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
Gunter von Minckwitz, Michael Untch, +14 authors, Sibylle Loibl.
J Clin Oncol, 2012 Apr 18; 30(15). PMID: 22508812
Highly Cited.
The evolution of paradigms for the management of breast cancer: a personal perspective.
B Fisher.
Cancer Res, 1992 May 01; 52(9). PMID: 1568206
BRCA1 and BRCA2: 1994 and beyond.
Steven A Narod, William D Foulkes.
Nat Rev Cancer, 2004 Sep 03; 4(9). PMID: 15343273
Highly Cited. Review.
Who discovered the lymphatic system.
B Chikly.
Lymphology, 1998 Feb 26; 30(4). PMID: 9476250
Gene expression profiling of breast cancer.
Ting Bao, Nancy E Davidson.
Adv Surg, 2008 Oct 29; 42. PMID: 18953822    Free PMC article.
Review.
On the myth of the Edwin Smith papyrus: is it magic or science?
Alexander Brawanski.
Acta Neurochir (Wien), 2012 Oct 18; 154(12). PMID: 23074022
Mammography: a history of success and scientific enthusiasm.
José Michel Kalaf.
Radiol Bras, 2015 Mar 06; 47(4). PMID: 25741098    Free PMC article.
Tumorigenicity of hypoxic respiring cancer cells revealed by a hypoxia-cell cycle dual reporter.
Anne Le, Zachary E Stine, +11 authors, Chi V Dang.
Proc Natl Acad Sci U S A, 2014 Aug 13; 111(34). PMID: 25114222    Free PMC article.
Estrogen metabolism and breast cancer.
Hamed Samavat, Mindy S Kurzer.
Cancer Lett, 2014 May 03; 356(2 Pt A). PMID: 24784887    Free PMC article.
Review.
Selective estrogen receptor modulators (SERMs) in clinical practice.
L Plouffe.
J Soc Gynecol Investig, 2000 Mar 25; 7(1 Suppl). PMID: 10732328
Review.
Tamoxifen Resistance: Emerging Molecular Targets.
Milena Rondón-Lagos, Victoria E Villegas, +2 authors, Peter G Zaphiropoulos.
Int J Mol Sci, 2016 Aug 23; 17(8). PMID: 27548161    Free PMC article.
Review.
The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer.
Steven A Narod.
Breast Cancer Res Treat, 2011 Apr 02; 128(2). PMID: 21455666
BRCA1 and BRCA2 mutations in Scotland and Northern Ireland.
Scottish/Northern Irish BRCAI/BRCA2 Consortium.
Br J Cancer, 2003 Apr 17; 88(8). PMID: 12698193    Free PMC article.
Aromatase, aromatase inhibitors, and breast cancer.
Saranya Chumsri, Timothy Howes, +2 authors, Angela Brodie.
J Steroid Biochem Mol Biol, 2011 Feb 22; 125(1-2). PMID: 21335088    Free PMC article.
Review.
The history of breast cancer advocacy.
Susan Braun.
Breast J, 2003 Apr 26; 9 Suppl 2. PMID: 12713506
Review.
Bernardino Ramazzini: the father of occupational medicine.
Malcolm H Pope.
Spine (Phila Pa 1976), 2004 Oct 14; 29(20). PMID: 15480150
Epidermal growth factor.
G Carpenter, S Cohen.
Annu Rev Biochem, 1979 Jan 01; 48. PMID: 382984
Highly Cited. Review.
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, +14 authors, A L Børresen-Dale.
Proc Natl Acad Sci U S A, 2001 Sep 13; 98(19). PMID: 11553815    Free PMC article.
Highly Cited.
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
Sandra M Swain, José Baselga, +12 authors, CLEOPATRA Study Group.
N Engl J Med, 2015 Feb 19; 372(8). PMID: 25693012    Free PMC article.
Highly Cited.
Exposure-response relationship of T-DM1: insight into dose optimization for patients with HER2-positive metastatic breast cancer.
J Wang, P Song, +12 authors, A Rahman.
Clin Pharmacol Ther, 2014 Feb 04; 95(5). PMID: 24488143
Triple-negative breast cancer--current status and future directions.
O Gluz, C Liedtke, +3 authors, N Harbeck.
Ann Oncol, 2009 Nov 11; 20(12). PMID: 19901010
Highly Cited. Review.
Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.
Richard Heery, Stephen P Finn, Sinead Cuffe, Steven G Gray.
Cancers (Basel), 2017 Apr 22; 9(4). PMID: 28430163    Free PMC article.
Highly Cited. Review.
PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer.
R-K Li, J- Gao, +2 authors, W-H Luo.
Cancer Gene Ther, 2017 Jul 22; 24(7). PMID: 28731027
Potential Diagnostic and Therapeutic Applications of Oligonucleotide Aptamers in Breast Cancer.
Xiaoqiu Wu, Atik Badshah Shaikh, +4 authors, Ge Zhang.
Int J Mol Sci, 2017 Aug 26; 18(9). PMID: 28841163    Free PMC article.
Review.
Screening Novel Molecular Targets of Metformin in Breast Cancer by Proteomic Approach.
Lobna Al-Zaidan, Rasha Abu El Ruz, Ahmed M Malki.
Front Public Health, 2017 Nov 01; 5. PMID: 29085821    Free PMC article.
Aptamer selection and applications for breast cancer diagnostics and therapy.
Mei Liu, Xiaocheng Yu, +9 authors, Nongyue He.
J Nanobiotechnology, 2017 Nov 15; 15(1). PMID: 29132385    Free PMC article.
Review.
The Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges.
Michaela Aubele, Manfred Schmitt, +8 authors, Marion Kiechle.
Dis Markers, 2017 Nov 16; 2017. PMID: 29138528    Free PMC article.
Review.
The regulatory roles of long non-coding RNAs in the development of chemoresistance in breast cancer.
Akshay Malhotra, Manju Jain, +2 authors, Aklank Jain.
Oncotarget, 2018 Jan 05; 8(66). PMID: 29299178    Free PMC article.
Review.
The mTOR inhibitor AZD8055 overcomes tamoxifen resistance in breast cancer cells by down-regulating HSPB8.
Jia-Jie Shi, Si-Meng Chen, +3 authors, Ling-Hua Meng.
Acta Pharmacol Sin, 2018 Jan 19; 39(8). PMID: 29345254    Free PMC article.
Anti-Tumor and Radiosensitization Effects of N-Butylidenephthalide on Human Breast Cancer Cells.
Yi-Ju Su, Sung-Ying Huang, +2 authors, Sheng-Chun Chiu.
Molecules, 2018 Jan 26; 23(2). PMID: 29370116    Free PMC article.
Diagnostic Accuracy of Digital Mammography in the Detection of Breast Cancer.
Muhammad Zeeshan, Basit Salam, +2 authors, Raza Sayani.
Cureus, 2018 Jun 12; 10(4). PMID: 29888152    Free PMC article.
Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines.
Aleksandra Simiczyjew, Ewelina Dratkiewicz, +3 authors, Dorota Nowak.
Cancers (Basel), 2018 Sep 20; 10(9). PMID: 30227653    Free PMC article.
Long noncoding RNA ROR promotes breast cancer by regulating the TGF-β pathway.
LingLi Hou, Jiancheng Tu, +6 authors, Guojun Zhou.
Cancer Cell Int, 2018 Sep 27; 18. PMID: 30250400    Free PMC article.
Estrogen alpha receptor antagonists for the treatment of breast cancer: a review.
Deepika Sharma, Sanjiv Kumar, Balasubramanian Narasimhan.
Chem Cent J, 2018 Oct 27; 12(1). PMID: 30361894    Free PMC article.
Review.
Involvement of the P2X7 receptor in the migration and metastasis of tamoxifen-resistant breast cancer: effects on small extracellular vesicles production.
Miso Park, Jieun Kim, +6 authors, Keon Wook Kang.
Sci Rep, 2019 Aug 14; 9(1). PMID: 31406126    Free PMC article.
Autotaxin and Breast Cancer: Towards Overcoming Treatment Barriers and Sequelae.
Matthew G K Benesch, Xiaoyun Tang, David N Brindley.
Cancers (Basel), 2020 Feb 12; 12(2). PMID: 32041123    Free PMC article.
Review.
The Effect of Health Literacy Counselling on Self-Care in Women after Mastectomy: a Randomized Clinical Trial.
Masoume Rastegar, Zohreh Mahmoodi, +2 authors, Kourosh Kabir.
J Caring Sci, 2020 Apr 17; 9(1). PMID: 32296658    Free PMC article.
Activation of JNK and p38 in MCF-7 Cells and the In Vitro Anticancer Activity of Alnus hirsuta Extract.
Mina Ryu, Chung Ki Sung, Young Jun Im, ChangJu Chun.
Molecules, 2020 Mar 04; 25(5). PMID: 32121012    Free PMC article.
Distribution and characteristics of androgen receptor (AR) in breast cancer among women in Addis Ababa, Ethiopia: A cross sectional study.
Endale Hadgu, Daniel Seifu, +6 authors, Mats G Karlsson.
PLoS One, 2020 May 07; 15(5). PMID: 32374753    Free PMC article.
Association of the genetic variants (-794 CATT5-8 and -173 G > C) of macrophage migration inhibitory factor (MIF) with higher soluble levels of MIF and TNFα in women with breast cancer.
Guadalupe Avalos-Navarro, Alicia Del Toro-Arreola, +9 authors, José Francisco Muñoz-Valle.
J Clin Lab Anal, 2020 Jan 25; 34(5). PMID: 31978276    Free PMC article.
Drug utilization and expenditure of anticancer drugs for breast cancer.
Bander Balkhi, Saeed Alqahtani, +4 authors, Yousif Asiri.
Saudi Pharm J, 2020 Jun 20; 28(6). PMID: 32550797    Free PMC article.
The concurrent effects of azurin and Mammaglobin-A genes in inhibition of breast cancer progression and immune system stimulation in cancerous BALB/c mice.
Payam Ghasemi-Dehkordi, Abbas Doosti, Mohammad-Saeid Jami.
3 Biotech, 2019 Jun 28; 9(7). PMID: 31245235    Free PMC article.
Co-expression based cancer staging and application.
Xiangchun Yu, Sha Cao, +2 authors, Ying Xu.
Sci Rep, 2020 Jul 02; 10(1). PMID: 32606385    Free PMC article.
Cytotoxic Potential of Petroleum ether, Ethyl Acetate, Chloroform, and Ethanol Extracts of Lavandula Coronopifolia Against Human Breast Carcinoma Cell line (MDA-MB-321).
Ebtesam S Al-Sheddi.
Asian Pac J Cancer Prev, 2019 Oct 28; 20(10). PMID: 31653139    Free PMC article.
Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT.
Guenther G Steger, Daniel Egle, +15 authors, Michael Gnant.
Breast, 2020 Feb 18; 50. PMID: 32062536    Free PMC article.
Polymorphism of XRCC3 in Egyptian Breast Cancer Patients.
Mona Khyri Alkasaby, Abeer Ibrahim Abd El-Fattah, Iman Hassan Ibrahim, Hesham Samir Abd El-Samie.
Pharmgenomics Pers Med, 2020 Aug 22; 13. PMID: 32821150    Free PMC article.
Knockdown of DNA/RNA-binding protein KIN17 promotes apoptosis of triple-negative breast cancer cells.
Xiang Gao, Zhenping Liu, +4 authors, Tao Zeng.
Oncol Lett, 2019 Jan 19; 17(1). PMID: 30655766    Free PMC article.
Prodigiosin/PU-H71 as a novel potential combined therapy for triple negative breast cancer (TNBC): preclinical insights.
Mohammed Moustapha Anwar, Manal Shalaby, +3 authors, Ahmed Hussein.
Sci Rep, 2020 Sep 09; 10(1). PMID: 32895397    Free PMC article.
In Silico Study on Tumor-Size-Dependent Thermal Profiles inside an Anthropomorphic Female Breast Phantom Subjected to Multi-Dipole Antenna Array.
Piotr Gas, Arkadiusz Miaskowski, Mahendran Subramanian.
Int J Mol Sci, 2020 Nov 19; 21(22). PMID: 33202658    Free PMC article.
Hydroalcoholic Extract of Levisticum officinale Increases cGMP Signaling Pathway by Down-Regulating PDE5 Expression and Induction of Apoptosis in MCF-7 and MDA-MB-468 Breast Cancer Cell Lines
Marzieh Lotfian Sargazi, Ramin Saravani, Ali Shahraki.
Iran Biomed J, 2018 Nov 06; 23(4). PMID: 30388886    Free PMC article.
Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in breast cancer.
Monireh Davoodian, Nadia Boroumand, +3 authors, Seyed Isaac Hashemy.
Mol Biol Rep, 2019 Jan 27; 46(1). PMID: 30684188
Polymorphism of DNA repair genes in breast cancer.
Beata Smolarz, Magdalena M Michalska, +2 authors, Luiza Wójcik.
Oncotarget, 2019 Feb 08; 10(4). PMID: 30728902    Free PMC article.
Potential use of Pichia pastoris strain SMD1168H expressing DNA topoisomerase I in the screening of potential anti‑breast cancer agents.
Jian Xin, Wan Nor Azlin Wan Mahtar, +2 authors, Boon Yin Khoo.
Mol Med Rep, 2019 May 07; 19(6). PMID: 31059050    Free PMC article.
Circulating soluble levels of MIF in women with breast cancer in the molecular subtypes: relationship with Th17 cytokine profile.
Guadalupe Avalos-Navarro, José Francisco Muñoz-Valle, +7 authors, Alicia Del Toro-Arreola.
Clin Exp Med, 2019 May 19; 19(3). PMID: 31102004
Encapsulation of Thermo-Sensitive Lauric Acid in Silica Shell: A Green Derivate for Chemo-Thermal Therapy in Breast Cancer Cell.
Valeria De Matteis, Mariafrancesca Cascione, +2 authors, Rosaria Rinaldi.
Molecules, 2019 May 31; 24(11). PMID: 31141939    Free PMC article.
Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancer.
Nitish Kumar, Harmandeep Kaur Gulati, +10 authors, Preet Mohinder Singh Bedi.
Mol Divers, 2020 Sep 05; 25(1). PMID: 32886304
Review.